Ratings by Canaccord (Edward Nash)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/19/2026 | Kiniksa | KNSA | New Coverage | Buy (N/A) |
45.39 (46.16) |
1.7% | Details | |
| 1/23/2026 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2026 | Ventyx Biosciences Inc | VTYX | Downgrade | Hold (Buy) |
10.05 (14.00) |
39.3% | Details | |
| 1/2/2026 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Veru, Inc. | VERU | New Coverage | Buy (N/A) |
2.23 (2.47) |
10.76% | Details | |
| 11/13/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Viking Therapeutic | VKTX | New Coverage | Buy (N/A) |
34.93 (32.98) |
-5.58% | Details | |
| 10/9/2025 | Akero Therapeutics | AKRO | Downgrade | Hold (Buy) |
46.49 (54.74) |
17.75% | Details | |
| 9/12/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2025 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2025 | Sagimet Biosciences Inc | SGMT | New Coverage | Buy (N/A) |
9.59 (5.41) |
-43.59% | Details | |
| 7/9/2025 | Verona Pharma | VRNA | Downgrade | Hold (Buy) |
86.86 (106.91) |
23.08% | Details | |
| 7/8/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2025 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (Buy) |
|
Details | ||
| 5/14/2025 | Apogee Therapeutics Inc | APGE | Maintain | Buy (Buy) |
|
Details | ||
| 5/2/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2025 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2025 | Pliant Therapeutics | PLRX | Downgrade | Hold (Buy) |
7.79 (1.33) |
-82.93% | Details | |
| 1/30/2025 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2024 | Apogee Therapeutics Inc | APGE | New Coverage | Buy (N/A) |
43.46 (73.05) |
68.09% | Details | |
| 11/5/2024 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2024 | Corcept Therapeutics | CORT | Maintain | Buy (Buy) |
|
Details | ||
| 8/15/2024 | Corcept Therapeutics | CORT | Maintain | Buy (Buy) |
|
Details | ||
| 8/12/2024 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2024 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2024 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2024 | Cardiol Therapeutics | CRDL | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2024 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2024 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2024 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2024 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Morphic Therapeutic | MORF | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2024 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2024 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2023 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Ventyx Biosciences Inc | VTYX | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2023 | Inventiva SA | IVA | New Coverage | Buy (N/A) |
3.64 (6.13) |
68.41% | Details | |
| 10/10/2023 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2023 | Intercept Pharmaceuticals | ICPT | Downgrade | Hold (Buy) |
10.44 (19.00) |
81.99% | Details | |
| 8/4/2023 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2023 | Intercept Pharmaceuticals | ICPT | Upgrade | Buy (Hold) |
10.90 (19.00) |
74.31% | Details | |
| 5/22/2023 | Intercept Pharmaceuticals | ICPT | Maintain | Hold (N/A) |
|
Details | ||
| 5/19/2023 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2023 | Cardiol Therapeutics | CRDL | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Pliant Therapeutics | PLRX | New Coverage | Buy (N/A) |
21.53 (1.33) |
-93.82% | Details | |
| 5/17/2023 | Oramed Pharma | ORMP | Maintain | Hold (N/A) |
|
Details | ||
| 5/17/2023 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Rani Therapeutics Holdsing s | RANI | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Theratechnologies Inc. | THTX | Maintain | Hold (N/A) |
|
Details | ||
| 2/28/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Corcept Therapeutics | CORT | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2023 | Oramed Pharma | ORMP | Downgrade | Hold (Buy) |
10.79 (3.29) |
-69.51% | Details | |
| 1/10/2023 | Amryt | AMYT | Downgrade | Hold (Buy) |
7.00 (14.70) |
110% | Details | |
| 1/6/2023 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Galmed Pharmaceuticals | GLMD | Downgrade | Hold (Buy) |
0.44 (0.66) |
50% | Details | |
| 8/2/2022 | Rezolute | RZLT | New Coverage | Buy (N/A) |
3.11 (3.11) |
0% | Details | |
| 7/29/2022 | ObsEva | OBSV | Downgrade | Hold (Buy) |
0.30 (0.10) |
-66.67% | Details | |
| 6/30/2022 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2022 | Corcept Therapeutics | CORT | New Coverage | Buy (N/A) |
23.80 (33.87) |
42.31% | Details | |
| 5/10/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Hold (N/A) |
|
Details | ||
| 4/26/2022 | ObsEva | OBSV | New Coverage | Buy (N/A) |
1.58 (0.10) |
-93.67% | Details | |
| 4/18/2022 | Cardiol Therapeutics | CRDL | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2022 | Morphic Therapeutic | MORF | New Coverage | Buy (N/A) |
40.32 (56.99) |
41.34% | Details | |
| 3/31/2022 | Ventyx Biosciences Inc | VTYX | New Coverage | Buy (N/A) |
13.03 (10.05) |
-22.87% | Details | |
| 3/8/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Hold (N/A) |
|
Details | ||
| 3/3/2022 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2021 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
2.05 (0.97) |
-52.68% | Details | |
| 11/23/2021 | Oramed Pharma | ORMP | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2021 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Galmed Pharmaceuticals | GLMD | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2021 | Metacrine Inc. | MTCR | Downgrade | Hold (Buy) |
3.71 (0.49) |
-86.79% | Details | |
| 9/17/2021 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Hold (N/A) |
|
Details | ||
| 7/29/2021 | Oramed Pharma | ORMP | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | Theratechnologies Inc. | THTX | Downgrade | Hold (Buy) |
3.71 (0.84) |
-77.36% | Details | |
| 5/17/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2021 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2021 | Galmed Pharmaceuticals | GLMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2021 | Oramed Pharma | ORMP | New Coverage | Buy (N/A) |
8.46 (3.29) |
-61.11% | Details | |
| 4/19/2021 | Theratechnologies Inc. | THTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2021 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | Verona Pharma | VRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Verona Pharma | VRNA | New Coverage | Buy (N/A) |
7.83 (106.91) |
1265.39% | Details | |
| 7/1/2020 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2020 | Akero Therapeutics | AKRO | New Coverage | Buy (N/A) |
26.09 (46.49) |
78.19% | Details | |
| 1/30/2020 | Madrigal Pharmaceuticals | MDGL | New Coverage | Buy (N/A) |
81.75 (432.83) |
429.46% | Details |
